Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 4Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 7Myeloid 1

Conditions

Myelodysplastic Syndromes 24Leukemia, Myeloid, Acute 23Myeloproliferative Disorders 16Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16Polycythemia Vera 10Primary Myelofibrosis 7Thrombocythemia, Essential 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia 4Polycythemia 3Lymphohistiocytosis, Hemophagocytic 3Leukemia, Myelomonocytic, Chronic 3Hematologic Neoplasms 3Hematologic Diseases 3Recurrence 2Myelodysplastic-Myeloproliferative Diseases 2Motor Activity 2Lymphoproliferative Disorders 2Lymphoma, Non-Hodgkin 2Lymphoma 2Epstein-Barr Virus Infections 2VEXAS syndrome 1Thyroid Carcinoma, Anaplastic 1Thyroid Cancer, Papillary 1Thrombophilia 1Thrombocytosis 1Thrombocytopenia 1Polycythemia, primary familial and congenital 1Pleural Effusion, Malignant 1

Interventions

Pleurodesis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Pleural Effusion, Malignant × Myeloid × Clear all
NCT06742099 2024-12-19

The Outcome of Inserting Intercostal Tube or Pleurodesis for Malignant Pleural Effusion

Assiut University

Phase EARLY_PHASE1 Not yet recruiting
20 enrolled
MyeloidThoracic

Myeloproliferative Disorder, Chronic, with Eosinophilia, Pleural Effusion, Malignant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡